Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy-Reference-Cited by-同舟云学术

Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy

Published:2019-12 Issue: Volume:150 Page:104511
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Abdel-Wahab Ali F.,Mahmoud Waheed,Al-Harizy Randa M.

Publisher

Elsevier BV

Subject

Pharmacology

Reference282 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA-Cancer J. Clin.,2018

2. Hypersensitization of tumor cells to glycolytic inhibitors;Liu;Biochemistry,2001

3. Glycolysis inhibition for anticancer treatment;Pelicano;Oncogene,2006

4. Tumor glycolysis as a target for cancer therapy: progress and prospects;Ganapathy-Kanniappan;Mol. Cancer,2013

5. Targeting glucose metabolism in cancer: new class of agents for loco-regional and systemic therapy of liver cancer and beyond? Hepat;Savic;Oncol.,2016

Cited by 347 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arsenic activated GLUT1-mTORC1/HIF-1α-PKM2 positive feedback networks promote proliferation and migration of bladder epithelial cells;Science of The Total Environment;2024-10

2. Investigating Therapies Targeting Druggable Targets of Mitochondria: Exploring the Efficacy for the Treatment of Cancer;ChemistrySelect;2024-09-09

3. Glycolysis, the sweet appetite of the tumor microenvironment;Cancer Letters;2024-09

4. The role of nonhistone lactylation in disease;Heliyon;2024-09

5. SGLT-2 inhibitors are beneficial in reducing the risk of thyroid cancer: findings from a Mendelian randomization study;Acta Diabetologica;2024-08-17